# Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore

> **NCT04534257** · NA · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 75 (actual)

## Conditions studied

- Critical Lower Limb Ischemia
- Peripheral Artery Disease

## Interventions

- **DEVICE:** SELUTION Sirolimus DCB

## Key facts

- **NCT ID:** NCT04534257
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-09
- **Primary completion:** 2021-12-20
- **Final completion:** 2022-05-20
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534257, "Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04534257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*